李康,丁燕生

• 1:北京大学第一医院心内科

摘要(Abstract)：

<正>本文重点介绍《2016年欧洲心脏病学会(European Society of Cardiology,ESC)急/慢性心力衰竭治疗指南》~[1](以下简称《2016年指南》)中关于射血分数降低的心力衰竭(heart failure with reduced ejection fraction,HFr EF)非外科置入装置治疗部分,主要包括埋藏式心律转复除颤器

关键词(KeyWords)： 心力衰竭;埋藏式心律转复除颤器;心脏再同步化治疗;指南解读

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李康,丁燕生

参考文献(References)：

• [1]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC.Eur Heart J,2016,pii:ehw128.
• [2]Mc Murray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC.Eur Heart J,2012,33(14):1787-1847.
• [3]Zannad F,De Ferrari GM,Tuinenburg AE,et al.Chronic vagal stimulation for the treatment of low ejection fraction heart failure:results of the NEural Cardiac Ther Apy foR Heart Failure(NECTAR-HF)randomized controlled trial.Eur Heart J,2015,36(7):425-433.
• [4]Ponikowski P,Javaheri S,Michalkiewicz D,et al.Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure.Eur Heart J,2012,33(7):889-894.
• [5]Abraham WT,Jagielski D,Oldenburg O,et al.Phrenic nerve stimulation for the treatment of central sleep apnea.JACC Heart Fail,2015,3(5):360-369.
• [6]Kadish A,Nademanee K,Volosin K,et al.A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.Am Heart J,2011,161(6):329-337.e2.
• [7]Borggrefe MM,Lawo T,Butter C,et al.Randomized,double blind study of non-excitatory,cardiac contractility modulation electrical impulses for symptomatic heart failure.Eur Heart J,2008,29(8):1019-1028.
• [8]Hohnloser SH,Kuck KH,Dorian P,et al.Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.N Engl J Med,2004,351:2481-2488.
• [9]Steinbeck G,Andresen D,Seidl K,et al.Defibrillator implantation early after myocardial infarction.N Engl J Med,2009,361(15):1427-1436.
• [10]Bardy GH,Smith WM,Hood MA,et al.An entirely subcutaneous implantable cardioverter-defibrillator.N Engl J Med,2010,363(1):36-44.
• [11]Aziz S,Leon AR,El-Chami MF.The subcutaneous defibrillator.J Am Coll Cardiol,2014,63(15):1473-1479.
• [12]Chung MK,Szymkiewicz SJ,Shao M,et al.Aggregate national experience with the wearable cardioverter-defibrillator.J Am Coll Cardiol,2010,56(3):194-203.
• [13]Bristow MR,Saxon LA,Boehmer J,et al.Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.N Engl J Med,2004,350(21):2140-2150.
• [14]Cleland J,Daubert J,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure.N Engl J Med,2005,352(15):1539-1549.
• [15]Cleland JGF,Daubert J-C,Erdmann E,et al.Longer-term effects of cardiac resynchronization therapy on mortality in heart failure[the CArdiac REsynchronization-Heart Failure(CAREHF)trial extension phase].Eur Heart J,2006,27(16):1928-1932.
• [16]Ruschitzka F,Abraham WT,Singh JP,et al.Cardiacresynchronization therapy in heart failure with a narrow QRS complex.N Engl J Med,2013,369(15):1395-1405.
• [17]Steffel J,Robertson M,Singh JP,et al.The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex:a subgroup analysis of the Echo CRT trial.Eur Heart J,2015,36(30):1983-1989.
• [18]Tang ASL,Wells GA,Talajic M,et al.Cardiacresynchronization therapy for mild-to-moderate heart failure.N Engl J Med,2010,363(25):2385-2395.
• [19]Funck RC,Mueller HH,Lunati M,et al.Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study(Bio Pace).Europace,2014,16(3):354-362.